ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,289, issued on Dec. 30, was assigned to The Chinese University of Hong Kong (Hong Kong SAR, China).
"Probiotic compositions for long COVID" was invented by Siew Chien Ng (Hong Kong), Ka Leung Francis Chan (New, China) and Qin Liu (Ma on Shan, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides for compositions and methods for treating long COVID symptoms or reducing the risk of developing such symptoms. More specifically, the present invention provides for compositions that comprises an effective amount of one or more beneficial bacterial species such as Bifidobacterium pseudocatenulatum and are useful for treating lo...